Margaret Coffman Rouquette passed peacefully surrounded by her adoring daughters on December 8, 2020, in New Braunfels, Texas. She was diagnosed with Frontotemporal Dementia (FTD) at age 65 and died one month before her 69th birthday.
Margaret was born January 24, 1952, in San Antonio, Texas. She is the daughter of Harriet Boddeker Coffman and Dr. Graham McDonald Coffman who preceded her in death. She is also preceded in death by her brother Graham Coffman. Margaret graduated from Alamo Heights High School in San Antonio. She attended Southern Methodist University in Dallas, graduated with her Master of Science in Speech-Language Pathology and was a member of the Delta Delta Delta sorority. Margaret taught for many years in the Garland Independent School District where she was an admired SLP to young children, including special needs students, and a respected mentor to graduate students at Texas Woman’s University.
Margaret was a beloved mother and friend and was referred to as a “saint” from her many friends. She had a way of making everyone around her feel welcomed and loved, and she truly saw the good in everyone. Her smile and laugh could light up the entire day. She connected with young women – her daughters’ friends, graduate students, and the nurses who loved her every day in her Memory Care residence – who were among some of her biggest admirers.
Margaret is survived by daughters Julianne Rouquette Cary and husband Mark A. Cary, and Lauren Rouquette Braun and husband William H. Braun III. She is also survived by her grandchildren Graham Alexander Cary and Caroline Grace Cary who loved her happy and giving spirit; her niece Cathy Gene Newton, and nephew Chad Coffman. She is preceded in death by her stepmother Betty Jane Coffman, and is survived by her stepfamily Sandie Cox, Cheryl Wilson, and Robert Caran.
Anyone wishing to honor Margaret’s legacy may consider a donation to the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Heath San Antonio that will support research in finding better ways to diagnose and treat the 50 million people living with Alzheimer’s disease and other neurodegenerative diseases.